Get started
Dare Bioscience, Inc.Dare Bioscience, Inc.Dare Bioscience, Inc.

Dare Bioscience, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

DARE trade ideas

DARE - Cup and Handle - longDare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, primarily in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health. This is not a financial advice! Cup and Handle ist forming We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work. We need to break 0.6! Keep an eye on 0.8 level, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains. SL under 0.45 TP approx. 0.8 Most info on the chart. Trade carefully!
NASDAQ:DARELong
by meitshels_smell_trades
1
Dare Biosciene, Inc - Hidden bullish divergence** risky investment opportunity - $26m market capital ** Happy with the risk? Then read on... This idea is the result of hours of study over numerous weeks. On the above 10-day chart price action has corrected an astonishing 99% over the last 6 years. Since early 2015 price action has printed lower highs and lower lows. Now is the time to be bullish. Why? 1) Trend reversal. Look closely, the bearish market structure was broken when a higher high printed in February. Since then price action has corrected to past resistance to confirm support - excellent. This support level is defined by the bottoming monthly candle. See monthly chart below. 2) The yearly EMA (green line). Price action has recently made an impulsive move to the upper side of the EMA while closing several candle bodies above - fantastic. 3) Hidden bullish divergence. Unlike regular bullish divergence, hidden bullish divergence is defined when an oscillator such as Stochastic RSI (diagonal pink lines) prints lower lows as price action prints higher lows. This is very bullish. Currently the Stochastic RSI is crossing up 20 (purple circle). This is very bullish on a 10-day chart. 4) Volume. I don’t know for what reasons money is pouring in, someone knows something I don’t - follow the money. Is it possible price action falls? For sure. Is it probable? Unlikely. A buy from 1.50 is amazing. Good luck! WW Monthly chart:
NASDAQ:DARELong
by without_worries
7
$DARE BULLISH HARMONIC CYPHER PATTERN$DARE BULLISH HARMONIC CYPHER PATTERN, BUILDS TWICE THE SCALE OVER TIME Volume uptick Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing products for women's health in the United States. The company develops therapies in the areas of contraception, fertility, and sexual and vaginal health. Its products in advanced clinical development include DARE-BV1, a bioadhesive hydrogel formulated with clindamycin phosphate 2% to treat bacterial vaginosis in a single administration that has completed Phase 3 clinical trials; Ovaprene, a hormone-free monthly vaginal contraceptive; and Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder. The company's Phase 1-ready products are DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for the treatment of vasomotor symptoms in hormone therapy; DARE-VVA1, a vaginally delivered formulation of tamoxifen to treat vulvar vaginal atrophy in patients with hormone-receptor positive breast cancer; and DARE-FRT1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth and broader luteal phase support as part of an in vitro fertilization treatment plan. Its products in pre-clinical stage include DARE-LARC1, a combination product designed to provide reversible contraception; ORB-204 and ORB-214, an injectable formulations of etonogestrel to provide contraception over 6-month and 12-month periods; and DARE-RH1, a non-hormonal contraception for men and women. The company is headquartered in San Diego, California.
NASDAQ:DARELong
by BADQOMOCAWGOWLD
$DARE is gonna fall todayPupm&Dump trading strategy idea. $DARE is rising too much today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $2,12; stop-loss — $2,22; take-profit — $1,92. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:DAREShort
by KozakHlib
2
$DARE is gonna fall todayPupm&Dump trading strategy idea. $DARE is rising too much today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $2,43; stop-loss — $2,64; take-profit — $2,02. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:DAREShort
by KozakHlib
DARE has potential for consistent growthWith the recent positive news and consistent volume, we believe more and more investors will discover this hidden gem within the coming days and weeks. It has recently climbed back above the 200 MA with volume and seems to be in an up-trend -- creating some support around $1.50 - $1.60. This range might be a good entry point for new investors wanting to go long on this one. All in all, this company seems to be poised for more and more growth, and we at Earth Jester Magazine expect that growth to be reflected in the price of the stock in the coming days, weeks, months, and years ahead. As always, we stress the fact that we are not financial advisors and investors should do their own research and due diligence before investing in any stock.
NASDAQ:DARELong
by EarthJester
$DARE can rise in the next daysContextual immersion trading strategy idea. Dare Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing products for women's health in the United States. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $1.68; stop-loss — $1.53. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:DARELong
by KozakHlib
2
DARE WITH NDA NEWS DARE is one of the great BioTech companies, they have a nice drug story (go read :) ) - they have a commitment to release an NDA during Q2 2021 with that the expectation based on the history and price movement can reach the TPs that is shown on the chart NB: this stock is getting pumped or news every 120ish candles - based on that if we have NDA news during Q2 we will see this price move else by July DISCLAIMER: I"M NOT A FINANCIAL ADVISOR, DO YOUR OWN DUE DILIGENCE, THIS IDEA FOR EDUCATIONAL PURPOSED ONLY
NASDAQ:DARELong
by Mo-le
DARE Morning Mover Alert UpdateMORNING MOVER ALERT UPDATE $DARE - Dare Bioscience, Inc. - Common Stock Initial Alert Price: $1.2 Price High: $2.68 % Gains/Losses: 123.33% (+98% More Than Expected) Potential Stop Loss: $2.546 DARE topped out at $2.68 in today's trading session on pure momentum. No press releases or catalyst to explain the move, but the stock provided a 96.67% Gain from our initial trade alert on the Dec. 18th, 2020. We are watching to stock to determine if this will consolidate heavy or find new support at these levels moving forward. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
NASDAQ:DARE
by MyMIWallet
1
DARE bullish upcoming catalysts in 2021 and 2022No Investment advice! Only for practicing. Interessting volume spikes in the past. Upcoming Catalsyst: NDA Filling DARE-BV1 Bacterial Vaginosis 1H 2021 Phase 3 trial met primary endpoint - December 7, 2020. NDA planned for 1H 2021. Phase 1 DARE-HRT1 Hormone replacement therapy 2021 Phase 1 initiation announced July 27, 2020. Data due 2021. Phase 2b Sildenafil Cream, 3.6% Female Sexual Arousal Disorder (FSAD) 2021 Phase 1 initiation announced July 27, 2020. Data due 2021. Phase 3 Ovaprene Contraception 2022 Pivotal trial data due in 2022.
NASDAQ:DARELong
by meitshels_smell_trades
1
Still bullish on DareIn EW there is always several possible patterns. Now it seems like that the best of the bearish patterns seems to suggest an upward move. It could be ranging from 1,54 to 1,79 (2 targets on 1,79) The first is a=c = 1,54 and the latter a 1,61 times a= (1,79) of wave c Thats the bearish bullish cases. However, IF the huge rise was the end of a wave I then it seems like wave II could have ended with a big normal retracement. In that light, wave 3 has ended its wave 1 of 5 and is now completing or has completed wave 2 down. And in that extreme case the next move should be (then w2 has finished if not already) be a wave 3 of 3. And that should give at target for the entire wave III to about 5 dollar (wave I equals 38% of the endpoint of that target). I guess thats the most bullish scenarie which could be in play. However i have no idea if the huge rise was wave I. It could be a wave C or even a wave A. Zacks has a target on dare on 5 dollars so that is not totally crazy. And I guess that target reflects probabilities for fda approval, rejection and so on. So lets assume DARE does rise the next week. What to do ? given it rises....then if it does so in a orderly matter - then stick to the correction targets 1,54 to 1,79. But if it does take gigantic daily rises...then maybe just hold your horses and enjoy the journey. I do have a position myself - 10000 shares - and even though i cant promise anything - the intention is to be long...very long in this share. That goes even if it should find a new bottom without any logical reason. then i will just wait and let time do its job regarding positive news (i hope). Best luck in trading.
NASDAQ:DARELong
by dclholm
Dare and Zig-zags well, one way to interpret elliott wave pattern on Dare could be this way. in the longer timeframe i have not a absolute wave pattern. So i have counted what you see on the chart. It looks like zig-zags on different degrees. longer term zig-zag should mean higher high eventually. medium term should mean lower than the correction of the intital big 5-way has shown until now. Short term should mean a pop-up before the medium term goes to action. the wave counts changes as the reality moves in. But right now----this could be the case.
NASDAQ:DARELong
by dclholm